Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global AI Cardiovascular Imaging Market Outlook, In‑Depth Analysis & Forecast to 2032
Global AI Cardiovascular Imaging Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Medical Devices & Consumables
Published Date: 2026-03-24
Pages: 123 Pages
Report ld: 6276540
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
AI Cardiovascular Imaging Market Size(US$)
CAGR 2026-2032
12.7%
Market Size,2032
USD 2,697
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 1,316 million
Market Forecast in 2032(Value)
US$ 2,697 million
CAGR
12.7%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global AI Cardiovascular Imaging market is projected to grow from US$ 1181 million in 2025 to US$ 2697 million by 2032, at a CAGR of 12.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
AI Cardiovascular Imaging refers to the use of artificial intelligence technology to analyze and process cardiovascular imaging data to assist doctors in faster and more accurate diagnosis, treatment planning and disease monitoring. This technology can improve the efficiency of the interpretation of cardiovascular images, reduce the workload of doctors, and may detect subtle abnormalities that are difficult for humans to recognize, thereby improving patient outcomes and outcomes
From a downstream perspective, Hospital accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
AI Cardiovascular Imaging leading players (including Cleerly, Inc, CathWorks, Ultromics Limited, Idoven, Arterys Inc., Philips, etc.), dominate supply; the top five capture approximately % of global revenue, with Cleerly, Inc leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global AI Cardiovascular Imaging market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Cleerly, Inc
- CathWorks
- Ultromics Limited
- Idoven
- Arterys Inc.
- Philips
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Ai-assisted Diagnostic System
- 3D Image Reconstruction Technology
- Automated Image Analysis
- Others
Segment by Application
- Hospital
- Ambulatory Surgery Centers
- Others
CHAPTER OUTLINE
Chapter 1: Defines the AI Cardiovascular Imaging study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to AI Cardiovascular Imaging: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global AI Cardiovascular Imaging Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Ai-assisted Diagnostic System
1.2.3 3D Image Reconstruction Technology
1.2.4 Automated Image Analysis
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global AI Cardiovascular Imaging Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Ambulatory Surgery Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global AI Cardiovascular Imaging Revenue Estimates and Forecasts (2021-2032)
2.2 Global AI Cardiovascular Imaging Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global AI Cardiovascular Imaging Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global AI Cardiovascular Imaging Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Ai-assisted Diagnostic System: Market Share by Key Players
3.3.2 3D Image Reconstruction Technology: Market Share by Key Players
3.3.3 Automated Image Analysis: Market Share by Key Players
3.3.4 Others: Market Share by Key Players
3.4 Global AI Cardiovascular Imaging Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global AI Cardiovascular Imaging Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global AI Cardiovascular Imaging Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America AI Cardiovascular Imaging Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America AI Cardiovascular Imaging Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe AI Cardiovascular Imaging Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe AI Cardiovascular Imaging Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific AI Cardiovascular Imaging Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific AI Cardiovascular Imaging Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America AI Cardiovascular Imaging Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America AI Cardiovascular Imaging Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa AI Cardiovascular Imaging Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa AI Cardiovascular Imaging Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Cleerly, Inc
11.1.1 Cleerly, Inc Corporation Information
11.1.2 Cleerly, Inc Business Overview
11.1.3 Cleerly, Inc AI Cardiovascular Imaging Product Features and Attributes
11.1.4 Cleerly, Inc AI Cardiovascular Imaging Revenue and Gross Margin (2021-2026)
11.1.5 Cleerly, Inc AI Cardiovascular Imaging Revenue by Product in 2025
11.1.6 Cleerly, Inc AI Cardiovascular Imaging Revenue by Application in 2025
11.1.7 Cleerly, Inc AI Cardiovascular Imaging Revenue by Geographic Area in 2025
11.1.8 Cleerly, Inc AI Cardiovascular Imaging SWOT Analysis
11.1.9 Cleerly, Inc Recent Developments
11.2 CathWorks
11.2.1 CathWorks Corporation Information
11.2.2 CathWorks Business Overview
11.2.3 CathWorks AI Cardiovascular Imaging Product Features and Attributes
11.2.4 CathWorks AI Cardiovascular Imaging Revenue and Gross Margin (2021-2026)
11.2.5 CathWorks AI Cardiovascular Imaging Revenue by Product in 2025
11.2.6 CathWorks AI Cardiovascular Imaging Revenue by Application in 2025
11.2.7 CathWorks AI Cardiovascular Imaging Revenue by Geographic Area in 2025
11.2.8 CathWorks AI Cardiovascular Imaging SWOT Analysis
11.2.9 CathWorks Recent Developments
11.3 Ultromics Limited
11.3.1 Ultromics Limited Corporation Information
11.3.2 Ultromics Limited Business Overview
11.3.3 Ultromics Limited AI Cardiovascular Imaging Product Features and Attributes
11.3.4 Ultromics Limited AI Cardiovascular Imaging Revenue and Gross Margin (2021-2026)
11.3.5 Ultromics Limited AI Cardiovascular Imaging Revenue by Product in 2025
11.3.6 Ultromics Limited AI Cardiovascular Imaging Revenue by Application in 2025
11.3.7 Ultromics Limited AI Cardiovascular Imaging Revenue by Geographic Area in 2025
11.3.8 Ultromics Limited AI Cardiovascular Imaging SWOT Analysis
11.3.9 Ultromics Limited Recent Developments
11.4 Idoven
11.4.1 Idoven Corporation Information
11.4.2 Idoven Business Overview
11.4.3 Idoven AI Cardiovascular Imaging Product Features and Attributes
11.4.4 Idoven AI Cardiovascular Imaging Revenue and Gross Margin (2021-2026)
11.4.5 Idoven AI Cardiovascular Imaging Revenue by Product in 2025
11.4.6 Idoven AI Cardiovascular Imaging Revenue by Application in 2025
11.4.7 Idoven AI Cardiovascular Imaging Revenue by Geographic Area in 2025
11.4.8 Idoven AI Cardiovascular Imaging SWOT Analysis
11.4.9 Idoven Recent Developments
11.5 Arterys Inc.
11.5.1 Arterys Inc. Corporation Information
11.5.2 Arterys Inc. Business Overview
11.5.3 Arterys Inc. AI Cardiovascular Imaging Product Features and Attributes
11.5.4 Arterys Inc. AI Cardiovascular Imaging Revenue and Gross Margin (2021-2026)
11.5.5 Arterys Inc. AI Cardiovascular Imaging Revenue by Product in 2025
11.5.6 Arterys Inc. AI Cardiovascular Imaging Revenue by Application in 2025
11.5.7 Arterys Inc. AI Cardiovascular Imaging Revenue by Geographic Area in 2025
11.5.8 Arterys Inc. AI Cardiovascular Imaging SWOT Analysis
11.5.9 Arterys Inc. Recent Developments
11.6 Philips
11.6.1 Philips Corporation Information
11.6.2 Philips Business Overview
11.6.3 Philips AI Cardiovascular Imaging Product Features and Attributes
11.6.4 Philips AI Cardiovascular Imaging Revenue and Gross Margin (2021-2026)
11.6.5 Philips Recent Developments
12 AI Cardiovascular Imaging Value Chain and Ecosystem Analysis
12.1 AI Cardiovascular Imaging Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 AI Cardiovascular Imaging Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global AI Cardiovascular Imaging Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global AI Cardiovascular Imaging Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global AI Cardiovascular Imaging Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global AI Cardiovascular Imaging Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global AI Cardiovascular Imaging Revenue by Region (US$ Million), 2021-2026
Table 5. Global AI Cardiovascular Imaging Revenue by Region (US$ Million), 2027-2032
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 7. Global AI Cardiovascular Imaging Revenue by Players (US$ Million), 2021-2026
Table 8. Global AI Cardiovascular Imaging Revenue-Based Market Share by Players (2021-2026)
Table 9. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 10. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on AI Cardiovascular Imaging Revenue, 2025
Table 11. Global AI Cardiovascular Imaging Average Gross Margin (%) by Player (2021 vs 2025)
Table 12. Global AI Cardiovascular Imaging Companies Headquarters
Table 13. Global AI Cardiovascular Imaging Market Concentration Ratio (CR5)
Table 14. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global AI Cardiovascular Imaging Revenue by Type (US$ Million), 2021-2026
Table 17. Global AI Cardiovascular Imaging Revenue by Type (US$ Million), 2027-2032
Table 18. Key Product Attributes and Differentiation
Table 19. Global AI Cardiovascular Imaging Revenue by Application (US$ Million), 2021-2026
Table 20. Global AI Cardiovascular Imaging Revenue by Application (US$ Million), 2027-2032
Table 21. AI Cardiovascular Imaging High-Growth Sectors Demand CAGR (2026-2032)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America AI Cardiovascular Imaging Growth Accelerators and Market Barriers
Table 25. North America AI Cardiovascular Imaging Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 26. Europe AI Cardiovascular Imaging Growth Accelerators and Market Barriers
Table 27. Europe AI Cardiovascular Imaging Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. Asia-Pacific AI Cardiovascular Imaging Growth Accelerators and Market Barriers
Table 29. Asia-Pacific AI Cardiovascular Imaging Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 30. Central and South America AI Cardiovascular Imaging Investment Opportunities and Key Challenges
Table 31. Central and South America AI Cardiovascular Imaging Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Middle East and Africa AI Cardiovascular Imaging Investment Opportunities and Key Challenges
Table 33. Middle East and Africa AI Cardiovascular Imaging Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 34. Cleerly, Inc Corporation Information
Table 35. Cleerly, Inc Description and Major Businesses
Table 36. Cleerly, Inc Product Features and Attributes
Table 37. Cleerly, Inc Revenue (US$ Million) and Gross Margin (2021-2026)
Table 38. Cleerly, Inc Revenue Proportion by Product in 2025
Table 39. Cleerly, Inc Revenue Proportion by Application in 2025
Table 40. Cleerly, Inc Revenue Proportion by Geographic Area in 2025
Table 41. Cleerly, Inc AI Cardiovascular Imaging SWOT Analysis
Table 42. Cleerly, Inc Recent Developments
Table 43. CathWorks Corporation Information
Table 44. CathWorks Description and Major Businesses
Table 45. CathWorks Product Features and Attributes
Table 46. CathWorks Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. CathWorks Revenue Proportion by Product in 2025
Table 48. CathWorks Revenue Proportion by Application in 2025
Table 49. CathWorks Revenue Proportion by Geographic Area in 2025
Table 50. CathWorks AI Cardiovascular Imaging SWOT Analysis
Table 51. CathWorks Recent Developments
Table 52. Ultromics Limited Corporation Information
Table 53. Ultromics Limited Description and Major Businesses
Table 54. Ultromics Limited Product Features and Attributes
Table 55. Ultromics Limited Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. Ultromics Limited Revenue Proportion by Product in 2025
Table 57. Ultromics Limited Revenue Proportion by Application in 2025
Table 58. Ultromics Limited Revenue Proportion by Geographic Area in 2025
Table 59. Ultromics Limited AI Cardiovascular Imaging SWOT Analysis
Table 60. Ultromics Limited Recent Developments
Table 61. Idoven Corporation Information
Table 62. Idoven Description and Major Businesses
Table 63. Idoven Product Features and Attributes
Table 64. Idoven Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. Idoven Revenue Proportion by Product in 2025
Table 66. Idoven Revenue Proportion by Application in 2025
Table 67. Idoven Revenue Proportion by Geographic Area in 2025
Table 68. Idoven AI Cardiovascular Imaging SWOT Analysis
Table 69. Idoven Recent Developments
Table 70. Arterys Inc. Corporation Information
Table 71. Arterys Inc. Description and Major Businesses
Table 72. Arterys Inc. Product Features and Attributes
Table 73. Arterys Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. Arterys Inc. Revenue Proportion by Product in 2025
Table 75. Arterys Inc. Revenue Proportion by Application in 2025
Table 76. Arterys Inc. Revenue Proportion by Geographic Area in 2025
Table 77. Arterys Inc. AI Cardiovascular Imaging SWOT Analysis
Table 78. Arterys Inc. Recent Developments
Table 79. Philips Corporation Information
Table 80. Philips Description and Major Businesses
Table 81. Philips Product Features and Attributes
Table 82. Philips Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Philips Recent Developments
Table 84. Technologies, Platforms and Infrastructure
Table 85. Distributors List
Table 86. Market Trends and Market Evolution
Table 87. Market Drivers and Opportunities
Table 88. Market Challenges, Risks, and Restraints
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global AI Cardiovascular Imaging Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Ai-assisted Diagnostic System Product Picture
Figure 3. 3D Image Reconstruction Technology Product Picture
Figure 4. Automated Image Analysis Product Picture
Figure 5. Others Product Picture
Figure 6. Global AI Cardiovascular Imaging Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Global AI Cardiovascular Imaging Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 8. Hospital
Figure 9. Ambulatory Surgery Centers
Figure 10. Others
Figure 11. AI Cardiovascular Imaging Report Years Considered
Figure 12. Global AI Cardiovascular Imaging Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 14. Global AI Cardiovascular Imaging Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Global AI Cardiovascular Imaging Revenue-Based Market Share by Region (2021-2032)
Figure 16. Global AI Cardiovascular Imaging Revenue-Based Market Share Ranking (2025)
Figure 17. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 18. Ai-assisted Diagnostic System Revenue-Based Market Share by Player in 2025
Figure 19. 3D Image Reconstruction Technology Revenue-Based Market Share by Player in 2025
Figure 20. Automated Image Analysis Revenue-Based Market Share by Player in 2025
Figure 21. Others Revenue-Based Market Share by Player in 2025
Figure 22. Global AI Cardiovascular Imaging Revenue-Based Market Share by Type (2021-2032)
Figure 23. Global AI Cardiovascular Imaging Revenue-Based Market Share by Application (2021-2032)
Figure 24. North America AI Cardiovascular Imaging Revenue YoY (US$ Million), 2021-2032
Figure 25. North America Top 5 Players AI Cardiovascular Imaging Revenue (US$ Million) in 2025
Figure 26. North America AI Cardiovascular Imaging Revenue (US$ Million) by Application (2021-2032)
Figure 27. US AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 28. Canada AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 29. Mexico AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 30. Europe AI Cardiovascular Imaging Revenue YoY (US$ Million), 2021-2032
Figure 31. Europe Top 5 Players AI Cardiovascular Imaging Revenue (US$ Million) in 2025
Figure 32. Europe AI Cardiovascular Imaging Revenue (US$ Million) by Application (2021-2032)
Figure 33. Germany AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 34. France AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 35. U.K. AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 36. Italy AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 37. Russia AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 38. Asia-Pacific AI Cardiovascular Imaging Revenue YoY (US$ Million), 2021-2032
Figure 39. Asia-Pacific Top 8 Players AI Cardiovascular Imaging Revenue (US$ Million) in 2025
Figure 40. Asia-Pacific AI Cardiovascular Imaging Revenue (US$ Million) by Application (2021-2032)
Figure 41. Indonesia AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 42. Japan AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 43. South Korea AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 44. Australia AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 45. India AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 46. Indonesia AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 47. Vietnam AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 48. Malaysia AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 49. Philippines AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 50. Singapore AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 51. Central and South America AI Cardiovascular Imaging Revenue YoY (US$ Million), 2021-2032
Figure 52. Central and South America Top 5 Players AI Cardiovascular Imaging Revenue (US$ Million) in 2025
Figure 53. Central and South America AI Cardiovascular Imaging Revenue (US$ Million) by Application (2021-2032)
Figure 54. Brazil AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 55. Argentina AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 56. Middle East and Africa AI Cardiovascular Imaging Revenue YoY (US$ Million), 2021-2032
Figure 57. Middle East and Africa Top 5 Players AI Cardiovascular Imaging Revenue (US$ Million) in 2025
Figure 58. Middle East and Africa AI Cardiovascular Imaging Revenue (US$ Million) by Application (2021-2032)
Figure 59. GCC Countries AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 60. Israel AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 61. Egypt AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 62. South Africa AI Cardiovascular Imaging Revenue (US$ Million), 2021-2032
Figure 63. AI Cardiovascular Imaging Value Chain Mapping
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of AI Cardiovascular Imaging in 2032?
The global market size of AI Cardiovascular Imaging in 2032 was 2697 Million USD.
Which companies rank high in the global AI Cardiovascular Imaging market?
What is the annual compound growth rate of the global AI Cardiovascular Imaging market size from 2026 to 2032?
Which region is expected to have the highest market share?
What was the global market size of AI Cardiovascular Imaging in 2026?
Related Reports
Global AI Cardiovascular Imaging Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Cardiovascular Imaging market size was US$ 1181 million in 2025 and is forecast to reach a readjusted size of US$ 2697 million by 2032 with a CAGR of 12.7% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 79
USD 4250.00
(Single User License)
AI Cardiovascular Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Cardiovascular Imaging was estimated to be worth US$ 1181 million in 2025 and is projected to reach US$ 2697 million, growing at a CAGR of 12.7% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 95
USD 3950.00
(Single User License)
Global AI Cardiovascular Imaging Market Research Report 2026
The global AI Cardiovascular Imaging market was valued at US$ 1181 million in 2025 and is anticipated to reach US$ 2697 million by 2032, at a CAGR of 12.7% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 109
USD 2900.00
(Single User License)
Global AI Cardiovascular Imaging Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI Cardiovascular Imaging market size was US$ 1060 million in 2024 and is forecast to a readjusted size of US$ 2420 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 80
USD 4250.00
(Single User License)
Global AI Cardiovascular Imaging Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Cardiovascular Imaging market is projected to grow from US$ 1060 million in 2024 to US$ 2420 million by 2031, at a CAGR of 12.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 118
USD 4900.00
(Single User License)
AI Cardiovascular Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI Cardiovascular Imaging was estimated to be worth US$ 1060 million in 2024 and is forecast to a readjusted size of US$ 2420 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 89
USD 3950.00
(Single User License)
Global AI Cardiovascular Imaging Market Research Report 2025
The global market for AI Cardiovascular Imaging was valued at US$ 1060 million in the year 2024 and is projected to reach a revised size of US$ 2420 million by 2031, growing at a CAGR of 12.7% during the forecast period.
Published Date: 2025-03-10
Pages: 77
USD 2900.00
(Single User License)
Global AI Cardiovascular Imaging Market Insights, Forecast to 2030
Valued at US$ 1060 million in 2024, the global AI Cardiovascular Imaging market is forecast to reach US$ 2172 million by 2030, at a CAGR of 12.7% during the forecast period.
Published Date: 2024-12-29
Pages: 124
USD 4900.00
(Single User License)
Global and United States AI Cardiovascular Imaging Market Report & Forecast 2024-2030
The global AI Cardiovascular Imaging revenue was US$ 930 million in 2023 and is forecast to a readjusted size of US$ 2172 million by 2030 with a CAGR of 12.7% during the review period (2024-2030).
Published Date: 2024-12-29
Pages: 97
USD 4350.00
(Single User License)
AI Cardiovascular Imaging- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI Cardiovascular Imaging was estimated to be worth US$ 930 million in 2023 and is forecast to a readjusted size of US$ 2172 million by 2030 with a CAGR of 12.7% during the forecast period 2024-2030.
Published Date: 2024-12-29
Pages: 93
USD 3950.00
(Single User License)
Global AI Cardiovascular Imaging Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Cardiovascular Imaging market size was US$ 1181 million in 2025 and is forecast to reach a readjusted size of US$ 2697 million by 2032 with a CAGR of 12.7% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 79
USD 4250.00 (Single User License)AI Cardiovascular Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Cardiovascular Imaging was estimated to be worth US$ 1181 million in 2025 and is projected to reach US$ 2697 million, growing at a CAGR of 12.7% from 2026 to 2032.
Published: 2026-01-19
Pages: 95
USD 3950.00 (Single User License)Global AI Cardiovascular Imaging Market Research Report 2026
The global AI Cardiovascular Imaging market was valued at US$ 1181 million in 2025 and is anticipated to reach US$ 2697 million by 2032, at a CAGR of 12.7% from 2026 to 2032.
Published: 2026-01-08
Pages: 109
USD 2900.00 (Single User License)Global AI Cardiovascular Imaging Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI Cardiovascular Imaging market size was US$ 1060 million in 2024 and is forecast to a readjusted size of US$ 2420 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 80
USD 4250.00 (Single User License)Global AI Cardiovascular Imaging Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Cardiovascular Imaging market is projected to grow from US$ 1060 million in 2024 to US$ 2420 million by 2031, at a CAGR of 12.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 118
USD 4900.00 (Single User License)AI Cardiovascular Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI Cardiovascular Imaging was estimated to be worth US$ 1060 million in 2024 and is forecast to a readjusted size of US$ 2420 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 89
USD 3950.00 (Single User License)Global AI Cardiovascular Imaging Market Research Report 2025
The global market for AI Cardiovascular Imaging was valued at US$ 1060 million in the year 2024 and is projected to reach a revised size of US$ 2420 million by 2031, growing at a CAGR of 12.7% during the forecast period.
Published: 2025-03-10
Pages: 77
USD 2900.00 (Single User License)Global AI Cardiovascular Imaging Market Insights, Forecast to 2030
Valued at US$ 1060 million in 2024, the global AI Cardiovascular Imaging market is forecast to reach US$ 2172 million by 2030, at a CAGR of 12.7% during the forecast period.
Published: 2024-12-29
Pages: 124
USD 4900.00 (Single User License)Global and United States AI Cardiovascular Imaging Market Report & Forecast 2024-2030
The global AI Cardiovascular Imaging revenue was US$ 930 million in 2023 and is forecast to a readjusted size of US$ 2172 million by 2030 with a CAGR of 12.7% during the review period (2024-2030).
Published: 2024-12-29
Pages: 97
USD 4350.00 (Single User License)AI Cardiovascular Imaging- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI Cardiovascular Imaging was estimated to be worth US$ 930 million in 2023 and is forecast to a readjusted size of US$ 2172 million by 2030 with a CAGR of 12.7% during the forecast period 2024-2030.
Published: 2024-12-29
Pages: 93
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now